These primary tumor imaging features are not significantly different compared to the ALK+ and ROS1+ NSCLC tumors included in our cohort (Table 2) or compared to prior reports on ALK or ROS1+ tumors [26,31,37,38,43]. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.